Sands Capital Life Sciences Pulse Fund III (DE), L.P.

13D and 13G Filings

13D/G filings
13G on 1 security
Location
Arlington, VA
CIK
0001998695
Form D filings
1 filing
All SEC filings
View on sec.gov
Issuer % of Class Filed
Schedule 13G · 1 security · passive
SpyGlass Pharma, Inc. 13G
SGP · 85220G109
7.8% 2/13/2026
Event 2/6/2026

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.